Suspension of trading

Company Carmat SA

Stocks

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 10:25:00 19/03/2026 pm IST			5-day change	1st Jan Change
0.0990 ^EUR	-.--%		-.--%	-

07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today

Business description: Carmat SA

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Number of employees: 153

Sales by Activity: Carmat SA

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Medical Products	9.33T	22.37L	5L	38.37L	73.44L

See all business segments

Geographical breakdown of sales: Carmat SA

Fiscal Period: December	2020 (EUR)	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)
Export	-	22.29L	2L	14.7L	35.86L
France	9.33T	-	1L	13.27L	33.83L
Unallocated	-	8T	1L	10.4L	4L

See all geographic segments

Executive Committee: Carmat SA

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025
Marc Grimmé CTO	Chief Tech/Sci/R&D Officer	-	01/12/2009
Alexandre Eleonore PRN	Corporate Officer/Principal	-	-

See CARMAT SA governance

Composition of the Board of Directors: Carmat SA

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017
Pierre Bastid CHM	Chairman	71	25/06/2024
Florent Battistella BRD	Director/Board Member	63	07/05/2021
David Coti BRD	Director/Board Member	41	07/05/2021
John Hernandez BRD	Director/Board Member	59	07/05/2021
Marie Pierre Merle Beral BRD	Director/Board Member	64	01/01/2023
Paolo Rampulla BRD	Director/Board Member	54	01/01/2023
Laurent Kirsch BRD	Director/Board Member	58	11/03/2023

Composition of the Board of Directors

Company details: Carmat SA

Carmat SA

36, avenue de l'Europe

78140, Vélizy-Villacoublay

+33 1 39 45 64 50

http://www.carmatsa.com

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT SA	-.--%	-.--%	-72.42%	-98.71%	70.8L
STRYKER CORPORATION	-6.15%	-5.66%	-20.54%	+2.86%	13TCr
SMITH & NEPHEW PLC	-3.51%	-2.41%	-0.45%	-5.59%	1.3TCr
GLAUKOS CORPORATION	-0.18%	+1.19%	+46.32%	+92.76%	896.56Cr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-0.52%	-0.94%	-50.84%	-73.25%	386.36Cr
DOUBLE MEDICAL TECHNOLOGY INC.	+2.97%	+6.03%	+23.68%	+49.54%	273.94Cr
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.47%	-11.78%	-18.69%	-28.77%	165.63Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+3.48%	-0.70%	-3.98%	-22.19%	158.61Cr
ENOVIS CORPORATION	-6.10%	-3.41%	-22.87%	-62.22%	151.1Cr
Average	-1.06%	+1.33%	-13.31%	-16.18%	1.78TCr
Weighted average by Cap.	-5.15%	+2.04%	-14.98%	+4.97%